Project Grant R01DA063220
Award Date
5/1/25
Completion Date
4/30/28
Dollars Obligated
$672K
Funding Federal Agency
Office of the Director
Awarding Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.310
Assistance Type
Project Grant
Place of Performance
Missouri, USA
Similar Awards
This $399,536 Project Grant was awarded by the National Institute on Drug Abuse (NIDA), a part of the National Institutes of Health (NIH), under the Drug Use and Addiction Research Programs (CFDA 93.279). The grant supports research to design, synthesize, and test non-opioid drug candidates that can help combat the national opioid crisis, with a focus on reversing the effects of synthetic opioids like fentanyl. The key goals are to: 1) Develop and characterize chemical lead compounds and control...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), is providing $340,000.00 to The Washington University in St. Louis, Missouri to conduct research on the role of the locus coeruleus-noradrenergic (LC-NE) system in fentanyl withdrawal and associated negative affective behaviors. The key objectives of this 2-year research project are to: 1) determine whether fentanyl withdrawal selectively modifies the...
This Project Grant award from the National Institutes of Health (NIH) under the Trans-NIH Research Support program (CFDA 93.310) provides $453,600.00 to the University of Chicago to investigate the physiological impacts of reversing fentanyl-induced cardiorespiratory collapse. The objective is to establish a foundational understanding of the cellular and systemic outcomes after reversing fentanyl overdose, including characterizing how fentanyl and its reversal impact oxygen consumption,...
The University of Chicago was awarded a $712,167 Project Grant from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310). The grant will fund research to investigate the mechanisms by which the opioid drug fentanyl activates the carotid body, a sensory organ that regulates breathing, in order to develop therapeutic strategies for mitigating opioid-induced respiratory depression (OIRD) - a major health concern. The project...
This Project Grant award from the National Institutes of Health (NIH) Office of the Director, funded under the Trans-NIH Research Support program (CFDA 93.310), aims to improve understanding of serotonin mechanisms involved in fentanyl-induced respiratory depression. The $1,378,272 award to the Regents of the University of Michigan, with a project period running from June 2024 to April 2027, will support research to: Determine the effect of fentanyl on the activity of serotonin neurons in the...
This federal Project Grant award of $1,213,117 was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The objective is to develop novel chemical probes targeting the sodium binding site of the mu opioid receptor (MOR) to achieve functional selectivity and therapeutic benefits. The primary products/services include: Synthesis and pharmacological characterization of bitopic ligands that engage both the orthosteric and...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), aims to develop new pharmacological treatments to reverse fentanyl overdose. The $475,500 award to Indiana University will fund research to screen a library of cannabidiol (CBD) analogs to identify negative allosteric modulators (NAMs) of the mu opioid receptor (MOR) that can attenuate fentanyl's effects across signaling pathways. The project will...
This Project Grant from the National Institutes of Health National Institute on Drug Abuse, under the Drug Abuse and Addiction Research Programs (CFDA 93.279), provides $640,000 to Olfa Thera, Inc. to develop new therapeutics targeting the OLFR78/OR51E2 receptor pathway in the carotid body. The goal is to identify OLFR78/OR51E2 agonists that can strongly stimulate carotid body activity and ventilation to reverse opioid-induced respiratory depression, without the side effects of existing...
This federal Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) provides $1,557,845 to Regents of the University of Michigan to investigate the brainstem mechanisms of opioid-induced respiratory depression. The proposed research aims to determine how non-opioid-sensitive neurons in the dorsolateral pons contribute to breathing failure during opioid overdose, with the goal of generating a more complete...
This $1,076,036 federal Project Grant award was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The grant aims to characterize electroencephalography (EEG) signatures in the prefrontal cortex (PFC) following chronic opioid use and modulation of PFC interneurons. Specifically, the research will: Test if individual differences in PFC theta power and PFC interneuron physiology correlate with fentanyl self-administration and...